A Safety Study of SGN-CD352A for Patients With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT02954796 · TERMINATED
Trial details
- NCT number
- NCT02954796
- Sponsor
- Seagen Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-01
- Primary completion
- 2019-07-17
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.